NQO1 and cancer: On the cancer front, a dual inhibitor of NQO1 and glutathione transferases, called MNPC (5-methyl-N-(5-nitro-thiazol-2-yl)-3-phenylisoxazole-4-carboxamide), has been synthesized and characterized [110].